600426:SSEShandong Hualu-Hengsheng Chemical Co., Ltd. Class A Analysis
Data as of 2026-06-03 - not real-time
CN¥29.74
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading just above its identified support level, with the market price hovering near the lower end of its recent range. A sub‑30 RSI signals that the shares are technically oversold, while the MACD remains in a bearish configuration, suggesting limited upside momentum in the near term. The 20‑day moving average sits above the current price, reinforcing the view that the market is still testing the downside. Overall price action is neutral, with no clear directional bias emerging from the short‑term indicators.
On the fundamentals side, revenue is expanding at a healthy double‑digit pace and margins, though modest, are comfortably positive. Return on equity exceeds ten percent and the company generates solid operating cash flow, supporting its ability to meet dividend commitments. Debt levels are elevated relative to equity, and free cash flow is slightly negative, which tempers the otherwise attractive earnings multiples. A discounted cash‑flow model places intrinsic value well below the market price, indicating that the stock is priced at a premium to its estimated fair value.
Volatility remains high, and the historical drawdown of nearly thirty percent underscores the potential for sizable price swings. The chemical sector faces medium regulatory and commodity‑price risk, while the company’s China‑centric exposure adds a moderate geographic dimension. Systematic risk appears muted given the low beta, and trading volume is stable, suggesting adequate liquidity. Investors should weigh the over‑priced valuation against the sustainable dividend and solid earnings when forming a position.
On the fundamentals side, revenue is expanding at a healthy double‑digit pace and margins, though modest, are comfortably positive. Return on equity exceeds ten percent and the company generates solid operating cash flow, supporting its ability to meet dividend commitments. Debt levels are elevated relative to equity, and free cash flow is slightly negative, which tempers the otherwise attractive earnings multiples. A discounted cash‑flow model places intrinsic value well below the market price, indicating that the stock is priced at a premium to its estimated fair value.
Volatility remains high, and the historical drawdown of nearly thirty percent underscores the potential for sizable price swings. The chemical sector faces medium regulatory and commodity‑price risk, while the company’s China‑centric exposure adds a moderate geographic dimension. Systematic risk appears muted given the low beta, and trading volume is stable, suggesting adequate liquidity. Investors should weigh the over‑priced valuation against the sustainable dividend and solid earnings when forming a position.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price near support
- oversold RSI
- bearish MACD
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- steady revenue growth
- sustainable dividend
- reasonable valuation relative to peers
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- elevated debt load
- high volatility
- stable cash flow and dividend
Key Metrics & Analysis
Financial Health
Revenue Growth7.40%
Profit Margin11.81%
P/E Ratio17.0
ROE11.61%
ROA6.24%
Debt/Equity32.31
P/B Ratio1.8
Op. Cash FlowCN¥4.2B
Free Cash FlowCN¥-65096360
Technical Analysis
TrendNeutral
RSI28.8
SupportCN¥29.02
ResistanceCN¥37.77
MA 20CN¥32.16
MA 50CN¥34.92
MA 200CN¥31.22
MACDBearish
VolumeStable
Fear & Greed Index92.77
Valuation
Fair ValueCN¥20.72
GradeFair
TypeBlend
Dividend Yield1.85%
Risk Assessment
Beta-0.35
Volatility34.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.